Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mycophenolate mofetil - Roche

Next Previous
X
Search
Drug Profile

Mycophenolate mofetil - Roche

Alternative Names: CellCept; Cellcept Capsules; ME MPA; Munoloc; R99; RS-61443

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche Palo Alto LLC
  • Developer Aspreva Pharmaceuticals Corporation; Chugai Pharmaceutical; Roche; Roche Palo Alto
  • Class Acyclic acids; Fatty acids; Small molecules
  • Mechanism of Action Immunosuppressants; Inosine monophosphate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Myasthenia gravis; Pemphigus vulgaris
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Heart transplant rejection; Liver transplant rejection; Lung transplant rejection; Lupus nephritis; Pancreas transplant rejection; Renal transplant rejection; Transplant rejection
  • Discontinued Multiple sclerosis; Myasthenia gravis; Pemphigus vulgaris; Psoriasis

Most Recent Events

  • 27 Apr 2023 Chugai Pharmaceuticals submits company opinion for mycophenolate mofetil for Systemic scleroderma to MHLW review committee (Chugai Pharmaceuticals pipeline, May 2023)
  • 14 May 2016 Launched for Lupus nephritis in Japan (PO, Capsule)
  • 14 May 2016 Launched for Lupus nephritis in Japan (PO, Powder)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top